Search

Your search keyword '"Joehlin-Price A"' showing total 194 results

Search Constraints

Start Over You searched for: Author "Joehlin-Price A" Remove constraint Author: "Joehlin-Price A"
194 results on '"Joehlin-Price A"'

Search Results

1. Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer

2. Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer

5. LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer

8. Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities

9. High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition

11. Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study

12. Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities

14. Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma

15. Case Report: Circulating Tumor DNA Fraction Analysis Using Ultra-Low-Pass Whole-Genome Sequencing Correlates Response to Chemoradiation and Recurrence in Stage IV Small-Cell Carcinoma of the Cervix - A Longitudinal Study

16. Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study

19. Predictors of response to immune checkpoint inhibition in a real world gynecologic cancer population

20. Case report: ACTH-secreting pituitary carcinoma metastatic to the liver in a patient with a history of atypical pituitary adenoma and Cushing’s disease

22. Supplementary Data from Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer

23. Data from Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer

24. Data from Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer

25. Supplementary Data from Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer

26. Additional file 1 of LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer

27. Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities

28. LCK Facilitates DNA Damage Repair by Stabilizing RAD51 and BRCA1 in the Nucleus of Chemoresistant Ovarian Cancer

30. 2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy

34. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer

35. 2022-RA-998-ESGO Intermediate-risk endometrial cancer: isolated tumor cells (ITC)versusnode-negative in sentinel lymph node mapping. An international multi-institutional comparative study

36. 2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy

41. Fallbericht: Analyse der zirkulierenden Tumor-DNA-Fraktion mittels Ultra-Low-Pass Whole-Genome Sequencing korreliert bei kleinzelligem Stage-IV-Zervixkarzinom mit Ansprechen auf Radiochemotherapie und Rezidivierung – Eine Längsschnittstudie

44. Treatment of Ipilimumab Induced Graves’ Disease in a Patient with Metastatic Melanoma

45. Molecularly Classified Uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features

46. Review of 189 Consecutive Female Genital Skin and Mucosal Biopsies Submitted to an Academic Dermatopathology Practice

47. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer

48. Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities

Catalog

Books, media, physical & digital resources